Latin America Prefilled Syringes Market (2026-2031)
The Latin America Prefilled Syringes Market was valued at $419.3 Million in 2026 and projected to reach to $614.3 Million by 2031, representing a compound annual growth rate of 7.9%. The Latin America prefilled syringes market is positioned for steady growth, expanding from USD 419.3 million in 2026 to USD 614.3 million by 2031 at a CAGR of 7.9%.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Prefilled Syringes Market Trends and Insights
- Latin America's healthcare infrastructure modernization and increasing adoption of injectable biologics are driving demand for prefilled syringe solutions across the region.
- In Latin America, the shift toward self-administration therapies and improved patient compliance has accelerated market penetration, particularly in chronic disease management segments. Latin America's prefilled syringes market benefits from rising pharmaceutical manufacturing investments and regulatory harmonization efforts across key markets including Brazil, Mexico, and Colombia.
- The region's growing middle-class population and expanding healthcare access are creating sustained demand for convenient, safe injection devices.
- Latin America's competitive landscape includes both multinational device manufacturers and emerging regional players adapting products to local healthcare needs and cost structures..
Key Market Statistics
- CAGR (2026-2031) 7.9% CAGR
- Market Size, 2026 ~USD 419.3 Million
- Forecast, 2031 ~USD 614.3 Million
- Geography Latin America
Latin America Prefilled Syringes Market Overview
Healthcare Infrastructure Modernization :
Latin America is experiencing significant investment in healthcare infrastructure modernization, driving adoption of advanced drug delivery systems including prefilled syringes across hospitals and clinics.
Injectable Biologics Adoption Surge :
Increasing prevalence of chronic diseases and growing patient access to biologic therapies is accelerating demand for prefilled syringe solutions as the preferred delivery mechanism in Latin America.
Brazil's Market Leadership :
Brazil dominates the Latin American prefilled syringes market with USD 244.2 million in market size, driven by its large population, advanced pharmaceutical sector, and expanding middle-class healthcare access.
Regulatory Support & Standardization :
Strengthening regulatory frameworks and harmonization of pharmaceutical standards across Latin American countries are facilitating market growth and encouraging manufacturer investments in the region.
Latin America Prefilled Syringes Market Dynamics
- This growth trajectory reflects the region's commitment to modernizing healthcare delivery systems and improving patient outcomes through advanced injectable therapies.
- Rising incidence of diabetes, autoimmune disorders, and cancer is fueling demand for convenient, safe drug delivery solutions. Key growth drivers include increased pharmaceutical company investments, improved healthcare reimbursement policies, and growing awareness of prefilled syringe benefits among healthcare providers and patients.
- While the Latin American market grows at 7.9% CAGR compared to the global rate of 10.9%, the region presents significant untapped potential as healthcare infrastructure continues to evolve and access to biologic medications expands across emerging markets within Latin America..
Related Ecosystem
Key Takeaways
- Latin America's prefilled syringes market grows at 7.9% CAGR from 2026 to 2031, reaching USD 614.3 million.
- Latin America's adoption of self-administered injectable therapies is accelerating market expansion in chronic disease management.
- Latin America benefits from pharmaceutical manufacturing investments and regulatory harmonization across Brazil, Mexico, and Colombia.
- Latin America's expanding healthcare access and growing middle-class population drive sustained demand for convenient injection devices.
Prefilled Syringes Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SAFETY PREFILLED SYRINGES (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.9% from 2026 to 2031 |
| Largest Segment | CONVENTIONAL PREFILLED SYRINGES (Type) |
| Market Size Base Year (Billions) | ~USD 8.66 (2026) |
| Revenue Forecast (Billions) | ~USD 14.53 (2031) |
| Segments Covered | Type, Design, Material, Application |
Latin America Prefilled Syringes Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Design
- Customized Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Single-Chamber Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Application
- Anaphylaxis
- Cancer
- Diabetes
- Ophthalmology
- Other Applications
- Rheumatoid Arthritis
- Thrombosis
Target Audience
- Pharmaceutical Manufacturers : Prefilled syringe manufacturers and pharmaceutical companies need Latin America market data to develop regional product strategies, optimize manufacturing capacity, and identify distribution partnerships.
- Healthcare Providers & Hospital Networks : Hospital administrators and healthcare facility operators require market insights to evaluate prefilled syringe adoption trends, procurement strategies, and patient care delivery improvements across Latin America.
- Medical Device Suppliers : Device manufacturers and suppliers need regional market intelligence to assess demand for prefilled syringe components, materials, and manufacturing equipment in Latin American markets.
- Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in Latin America require market sizing, growth projections, and competitive analysis to inform investment decisions in prefilled syringe companies.
- Healthcare Consultants & Analysts : Market research professionals and healthcare consultants need comprehensive Latin America data to support client advisory services, competitive benchmarking, and strategic planning initiatives.
Key Companies in the Latin America Prefilled Syringes Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Conventional prefilled syringe automation,Safety prefilled syringe automation,Glass prefilled syringe–focused systems, |
| CONSORT MEDICAL | United Kingdom | Private Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| HENRY SCHEIN | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| FLUOR CORPORATION | United States | Public Company | Conventional Prefilled Syringe Infrastructure,Safety Prefilled Syringe Infrastructure,Glass Prefilled Syringe Facilities, |
| MERIT MEDICAL | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| GUERBET GROUP | France | InvalidIdentifier | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| BECTON, DICKINSON AND COMPANY (BD) | United States | ||
| GERRESHEIMER AG | Germany | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| SCHOTT | Germany | Public Company | Glass prefilled syringes (syriQ, syriQ BioPure, silicone-free),Polymer prefilled syringes (TOPPAC portfolio),Cartridges (cartriQ, dual-chamber, large volume), |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringe containment and components, |
| APTARGROUP, INC. | United States | Public Company | Conventional prefilled syringe components,Safety prefilled syringe and device-integrated systems,Glass prefilled syringe-related solutions, |
| NIPRO | Japan | Public Company | Glass Prefilled Syringe,Plastic Prefilled Syringe,Conventional Prefilled Syringe, |
| NOVARTIS AG | Switzerland | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringe, |
| STEVANATO GROUP | Italy | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| POLYMEDICURE | India | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| SHARPS TECHNOLOGY, INC. | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems for industrial applications.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical devices and pharmaceutical sectors.
HENRY SCHEIN
Henry Schein is a United States public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to dental, medical, and veterinary markets.
FLUOR CORPORATION
Fluor Corporation is a United States public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services to the energy, chemicals, and infrastructure sectors.
MERIT MEDICAL
Merit Medical is a United States public company founded in 1987 with 7,500 employees. The company designs, manufactures, and distributes medical devices for interventional medicine and vascular access.
GUERBET GROUP
Guerbet Group is a French company in the medical imaging and pharmaceutical sectors. Specific operational details are unavailable.
BECTON, DICKINSON AND COMPANY (BD)
Becton, Dickinson and Company (BD) is a United States-based medical technology company. Specific founding date and employee count details are unavailable.
GERRESHEIMER AG
Gerresheimer AG is a German public company founded in 1864 with 13,528 employees. The company manufactures specialty glass and plastic products for the pharmaceutical and healthcare industries.
SCHOTT
Schott is a German public company founded in 1884 with 4,839 employees. The company produces specialty glass and glass-ceramic products for pharmaceutical, laboratory, and industrial applications.
WEST PHARMACEUTICAL SERVICES, INC.
West Pharmaceutical Services, Inc. is a United States public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for injectable drugs and healthcare products.
APTARGROUP, INC.
AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees. The company designs and manufactures dispensing systems and closures for the pharmaceutical, beauty, and food industries.
NIPRO
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.
NOVARTIS AG
Novartis AG is a Swiss public company founded in 1996 with 75,267 employees. The company is a global pharmaceutical and healthcare company developing innovative medicines and treatments.
STEVANATO GROUP
Stevanato Group is an Italian public company founded in 1949 with 6,010 employees. The company manufactures glass and plastic packaging solutions for the pharmaceutical industry.
POLYMEDICURE
Polymedicure is an Indian public company founded in 1995 with 3,082 employees. The company manufactures and distributes medical devices and healthcare products.
SHARPS TECHNOLOGY, INC.
Sharps Technology, Inc. is a United States public company founded in 2017. Specific employee count details are unavailable.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 244.2 Million |
| Mexico | USD 99.6 Million |
| Argentina | USD 61.6 Million |
| Rest Of Latin America | USD 84.8 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Segmentation : Gain detailed insights into Latin America's prefilled syringes market with country-level breakdowns including Brazil, Mexico, and Argentina, enabling targeted market entry and expansion strategies.
- Growth Opportunity Assessment : Identify high-growth segments within Latin America's 7.9% CAGR market expansion, with forecasts through 2031 to support long-term business planning and investment decisions.
- Competitive Landscape Intelligence : Understand market dynamics specific to Latin America, including regulatory environment, healthcare infrastructure trends, and competitive positioning of prefilled syringe manufacturers in the region.
- Healthcare Infrastructure Insights : Access analysis of Latin America's modernizing healthcare systems and their impact on prefilled syringe adoption, helping stakeholders align products with regional healthcare delivery trends.
- Strategic Partnership Opportunities : Identify key markets and growth drivers in Latin America to inform partnership strategies, distribution agreements, and manufacturing facility locations across the region.
Frequently asked questions
What is the market size of prefilled syringes in Latin America?
In Latin America, the prefilled syringes market is estimated at USD 419.3 million in 2026 and is forecast to reach USD 614.3 million by 2031.
What is the growth rate for prefilled syringes in Latin America?
Latin America's prefilled syringes market is expected to grow at a compound annual growth rate (CAGR) of 7.9% between 2026 and 2031.
Which countries drive the prefilled syringes market in Latin America?
In Latin America, key markets include Brazil, Mexico, and Colombia, where pharmaceutical manufacturing investments and regulatory harmonization are supporting market growth.
What factors are driving prefilled syringe demand in Latin America?
Latin America's market growth is driven by healthcare infrastructure modernization, adoption of injectable biologics, self-administration therapies, and expanding healthcare access across the region.
Who are the main competitors in Latin America's prefilled syringes market?
Latin America's competitive landscape includes multinational device manufacturers and emerging regional players adapting products to local healthcare needs and cost structures.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current prefilled syringes market size. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the prefilled syringes market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the prefilled syringes market is provided below:
**Others include sales, marketing, and product managers.
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the prefilled syringes market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the prefilled syringes market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall prefilled syringes market was obtained from secondary data and validated by primary participants to arrive at the total prefilled syringes market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by prefilled syringes and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall prefilled syringes market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Prefilled Syringes Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Prefilled syringes are a convenient way to deliver parenteral medications or a single-dose packet of medication with a premeasured dose. This method of drug administration offers advantages for manufacturers in terms of reducing drug waste and extending product lifespan. Additionally, it provides ease of self-administration for patients at home and in non-hospital settings. Some examples of drugs packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.
Key Stakeholders
- Product manufacturers, distributors, and suppliers
- Research laboratories
- Academic universities and medical research centers
- R&D centers
- Business research and consulting firms
- Biotechnology companies
- Hospitals
- Clinical centers
- Pharmaceutical companies
- Medical research laboratories
- Consulting firms
Report Objectives
- To describe, analyze, and forecast the prefilled syringes market by type, design, material, application, and region
- To describe and forecast the prefilled syringes market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the prefilled syringes market
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the prefilled syringes market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the prefilled syringes market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of Europe prefilled syringes market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Asia Pacific prefilled syringes market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Latin America prefilled syringes market into Colombia, Peru, and other countries.
Get the Full Prefilled Syringes Market Report
Full forecast, segment splits, and company analysis for all Prefilled Syringes Market.
- Canada Prefilled Syringes Market
- US Prefilled Syringes Market
- Germany Prefilled Syringes Market
- UK Prefilled Syringes Market
- France Prefilled Syringes Market
- Spain Prefilled Syringes Market
- Italy Prefilled Syringes Market
- Japan Prefilled Syringes Market
- China Prefilled Syringes Market
- India Prefilled Syringes Market
- Australia Prefilled Syringes Market
- South Korea Prefilled Syringes Market
- Brazil Prefilled Syringes Market
- Mexico Prefilled Syringes Market
- Argentina Prefilled Syringes Market
- GCC Countries Prefilled Syringes Market
- Rest Of Europe Prefilled Syringes Market
- Rest Of Asia Pacific Prefilled Syringes Market
- Rest Of Latin America Prefilled Syringes Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report